The ghrelin axis--does it have an appetite for cancer progression?

Abstract

Ghrelin, the endogenous ligand for the GH secretagogue receptor (GHSR), is a peptide hormone with diverse physiological roles. Ghrelin regulates GH release, appetite and feeding, gut motility, and energy balance and also has roles in the cardiovascular, immune, and reproductive systems. Ghrelin and the GHSR are expressed in a wide range of normal and tumor tissues, and a fluorescein-labeled, truncated form of ghrelin is showing promise as a biomarker for prostate cancer. Plasma ghrelin levels are generally inversely related to body mass index and are unlikely to be useful as a biomarker for cancer, but may be useful as a marker for cancer cachexia. Some single nucleotide polymorphisms in the ghrelin and GHSR genes have shown associations with cancer risk; however, larger studies are required. Ghrelin regulates processes associated with cancer, including cell proliferation, apoptosis, cell migration, cell invasion, inflammation, and angiogenesis; however, the role of ghrelin in cancer is currently unclear. Ghrelin has predominantly antiinflammatory effects and may play a role in protecting against cancer-related inflammation. Ghrelin and its analogs show promise as treatments for cancer-related cachexia. Further studies using in vivo models are required to determine whether ghrelin has a role in cancer progression.

• Authors: Lisa K Chopin, Inge Seim, Carina M Walpole, Adrian C Herington
• Journal: Endocrine reviews (Endocr Rev) Vol. 33 Issue 6 Pg. 849-91 (Dec 2012) ISSN: 1945-7189 [Electronic] United States
• PMID: 22826465 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Ghrelin
• Receptors, Ghrelin

Topics

• Animals
• Cachexia (drug therapy)
• Cell Line, Tumor
• Disease Progression
• Ghrelin (metabolism, therapeutic use)
• Humans
• Neoplasms (metabolism)
• Receptors, Ghrelin (metabolism)